Complement activation in patients with COVID-19: A novel therapeutic target

被引:203
作者
Cugno, Massimo [1 ,2 ]
Meroni, Pier Luigi [3 ]
Gualtierotti, Roberta [1 ,2 ]
Griffini, Samantha [1 ,2 ]
Grovetti, Elena [1 ,2 ]
Torri, Adriana [2 ]
Panigada, Mauro [4 ,5 ]
Aliberti, Stefano [1 ,5 ]
Blasi, Francesco [1 ,5 ]
Tedesco, Francesco [3 ]
Peyvandi, Flora [1 ,2 ]
机构
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] IRCCS Ist Auxol Italiano, Immunorheumatol Res Lab, Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Anestesia & Terapia Intens Adulti, Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Pneumol, Milan, Italy
关键词
D O I
10.1016/j.jaci.2020.05.006
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:215 / +
页数:4
相关论文
共 9 条
[1]   HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN EXERTS ITS BENEFICIAL EFFECT IN PATIENTS WITH DERMATOMYOSITIS BY BLOCKING ENDOMYSIAL DEPOSITION OF ACTIVATED COMPLEMENT FRAGMENTS [J].
BASTA, M ;
DALAKAS, MC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1729-1735
[2]   Clinical and immunological features of severe and moderate coronavirus disease 2019 [J].
Chen, Guang ;
Wu, Di ;
Guo, Wei ;
Cao, Yong ;
Huang, Da ;
Wang, Hongwu ;
Wang, Tao ;
Zhang, Xiaoyun ;
Chen, Huilong ;
Yu, Haijing ;
Zhang, Xiaoping ;
Zhang, Minxia ;
Wu, Shiji ;
Song, Jianxin ;
Chen, Tao ;
Han, Meifang ;
Li, Shusheng ;
Luo, Xiaoping ;
Zhao, Jianping ;
Ning, Qin .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2620-2629
[3]  
Diao B, 2020, MEDRXIV, DOI [10.1101/2020.03.04.20031120, 10.1101]
[4]  
Gao T., 2020, HIGHLY PATHOGENIC CO, DOI DOI 10.1101/2020.03.29.20041962
[5]   Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis [J].
Gralinski, Lisa E. ;
Sheahan, Timothy P. ;
Morrison, Thomas E. ;
Menachery, Vineet D. ;
Jensen, Kara ;
Leist, Sarah R. ;
Whitmore, Alan ;
Heise, Mark T. ;
Baric, Ralph S. .
MBIO, 2018, 9 (05)
[6]  
Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203
[7]   Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics [J].
Patriquin, Christopher J. ;
Kuo, Kevin H. M. .
TRANSFUSION MEDICINE REVIEWS, 2019, 33 (04) :256-265
[8]   Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches [J].
Riedl, Magdalena ;
Fakhouri, Fadi ;
Le Quintrec, Moglie ;
Noone, Damien G. ;
Jungraithmayr, Therese C. ;
Fremeaux-Bacchi, Veronique ;
Licht, Christoph .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (04) :444-464
[9]   Endothelial cell infection and endotheliitis in COVID-19 [J].
Varga, Zsuzsanna ;
Flammer, Andreas J. ;
Steiger, Peter ;
Haberecker, Martina ;
Andermatt, Rea ;
Zinkernagel, Annelies S. ;
Mehra, Mandeep R. ;
Schuepbach, Reto A. ;
Ruschitzka, Frank ;
Moch, Holger .
LANCET, 2020, 395 (10234) :1417-1418